Browse the full insider trade history of 宏源药业, a publicly traded company based in France. Shares trade on FR FR, under the oversight of AMF. Market capitalisation: €10bn. The latest transaction was disclosed on 8 August 2024 — Sale. Among the most active insiders: 雷高良. Every trade is free.